Wistar Researchers Discover Potential Target for Gastric Cancers Associated with Epstein-Barr Virus
August 22, 2023 15:02 ET
|
The Wistar Institute
PHILADELPHIA, PA, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results...
Award-Winning Biotech Training Program Connects Philadelphians with Quality Jobs in the Region’s Rapidly Growing Life Sciences Sector
August 14, 2023 11:14 ET
|
The Wistar Institute
PHILADELPHIA, PA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Partners in Greater Philadelphia’s life sciences ecosystem are expanding their commitment to connecting a wider range of Philadelphians, including...
New Community Partnership Model Boosts Participant Inclusion into HIV Cure-Directed Research
August 08, 2023 13:11 ET
|
The Wistar Institute
PHILADELPHIA, PA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Scientists have long used community advisory boards to engage communities and provide feedback on studies, but this model has limitations. Now,...
Wistar-Led Team Awarded More Than $12 Million Grant from the NCI to Investigate Link Between Epstein-Barr Virus and Carcinomas
July 26, 2023 10:21 ET
|
The Wistar Institute
PHILADELPHIA, PA, July 26, 2023 (GLOBE NEWSWIRE) -- It’s been known since the 1960s that Epstein-Barr Virus (EBV) causes a variety of cancers, but research has overwhelmingly focused on its...
Wistar Scientists Discover Innate Tumor Suppression Mechanism
May 04, 2023 10:34 ET
|
The Wistar Institute
PHILADELPHIA, PA, May 04, 2023 (GLOBE NEWSWIRE) -- The p53 gene is one of the most important in the human genome: the only role of the p53 protein that this gene encodes is to sense when a tumor is...
Researchers Identify a Plant-based Compound that Inhibits Reactivation of the HIV Viral Reservoir
March 30, 2023 10:07 ET
|
The Wistar Institute
PHILADELPHIA, March 30, 2023 (GLOBE NEWSWIRE) -- As of 2022, approximately 1.2 million people in the United States are living with HIV. Antiretroviral therapies have enabled many of these...
Wistar Scientists Identify a Gene Signature to Assess Cancer Risk in People
February 06, 2023 15:45 ET
|
The Wistar Institute
PHILADELPHIA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar’s Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and...
Wistar Institute HIV Researchers Win Grant to Explore Genetically Engineered Natural Killer Cells as HIV Therapy
January 19, 2023 14:44 ET
|
The Wistar Institute
PHILADELPHIA, PA, Jan. 19, 2023 (GLOBE NEWSWIRE) -- amfAR, The Foundation for AIDS Research, has awarded Luis J. Montaner, D.V.M., D.Phil., in collaboration with Mohamed Abdel-Mohsen, Ph.D., a...
Wistar Institute’s Maureen Murphy Named Deputy Director of the Ellen and Ronald Caplan Cancer Center
January 13, 2023 09:18 ET
|
The Wistar Institute
PHILADELPHIA, PA, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Maureen Murphy, Ph.D., has been named Deputy Director of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute. Murphy will guide the...
Collaboration Advances DNA-delivered Antibodies to Prevent COVID-19
July 07, 2022 10:00 ET
|
The Wistar Institute
Philadelphia, PA, July 07, 2022 (GLOBE NEWSWIRE) -- PHILADELPHIA — (July 7, 2022) — Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical,...